Skip to content
Search

Latest Stories

Jhoots Pharmacy acquires 36 community pharmacies with HSBC UK funding

Jhoots Pharmacy acquires 36 community pharmacies with HSBC UK funding

The £17.4 million deal is expected to protect 212 jobs and create up to 130 new roles 

Leading health business Jhoots Pharmacy, which owns and operates 63 sites across the UK, has bought 36 more community pharmacies with a £17.4 million funding package from HSBC UK.


The funding will be used to acquire the sites across the UK which were previously owned and managed by Lloyds Pharmacy, and the deal is expected to protect 212 jobs and create up to 130 new roles.

The sites acquired by the independent group span from the Peak District to Hampshire, including six in Wales.

With this funding, Jhoots Pharmacy also plans to undertake refits and enhance pharmacy offerings to provide local communities access to urgent care services, which in turn will help alleviate GP waiting times.

Besides securing jobs, the business is actively hiring for up to 130 new roles, including pharmacists and qualified dispensers, while also increasing opportunities for apprentices and trainees.

Sarbjit Jhooty, Business Development Director at Jhoots Pharmacy, said: “We were looking for the right banking partner to support our business and our vision to grow into a larger pharmacy chain. With HSBC UK’s backing, we’re committed to providing a service that puts the community first, with a strong face-to-face approach that will offer enhanced support to local areas.”

Partho Bose, Relationship Director at HSBC UK, stressed the importance of improving access to care in the UK, and said they are providing Jhoots Pharmacy with financial foundations to “realise the business’s ambitious growth plans as well as protecting and creating jobs.”

Jhoots Pharmacy offers a full range of Essential, Advanced and Enhanced NHS Services as operated by the Local Commissioners.

Lead image: L-R: Partho Bose, HSBC UK, Sarbjit Singh Jhooty, Manjit Singh Jhooty

(Image credit: Dave Warren/Picture Team)

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less